- Preview Available
- Scholarly Journal
Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials
Infectious Diseases and Therapy; Philadelphia Vol. 6, Iss. 4, (Dec 2017): 515-529.
DOI:10.1007/s40121-017-0171-0
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.